RMFCX
Price
$54.22
Change
-$1.42 (-2.55%)
Updated
Dec 18 closing price
TWADX
Price
$7.60
Change
-$0.18 (-2.31%)
Updated
Dec 18 closing price
Ad is loading...

RMFCX vs TWADX

Header iconRMFCX vs TWADX Comparison
Open Charts RMFCX vs TWADXBanner chart's image
American Funds American Mutual R3
Price$54.22
Change-$1.42 (-2.55%)
VolumeN/A
CapitalizationN/A
American Century Value A
Price$7.60
Change-$0.18 (-2.31%)
VolumeN/A
CapitalizationN/A
RMFCX vs TWADX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RMFCX vs. TWADX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RMFCX is a Buy and TWADX is a StrongSell.

FUNDAMENTALS
Fundamentals
RMFCX has more cash in the bank: 98.7B vs. TWADX (1.98B). TWADX (1.75) and RMFCX (1.69) have matching dividends . RMFCX was incepted earlier than TWADX: RMFCX (23 years) vs TWADX (28 years). TWADX is a more actively managed with annual turnover of: 42.00 vs. RMFCX (25.00). RMFCX has a lower initial minimum investment than TWADX: RMFCX (250) vs TWADX (2500). RMFCX annual gain was more profitable for investors over the last year : 12.63 vs. TWADX (-2.68). RMFCX return over 5 years is better than : 40.39 vs. TWADX (0.97).
RMFCXTWADXRMFCX / TWADX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence23 years28 years-
Gain YTD11.4231.212943%
Front LoadN/AN/A-
Min. Initial Investment250250010%
Min. Initial Investment IRAN/AN/A-
Net Assets98.7B1.98B4,977%
Annual Yield % from dividends1.691.7597%
Returns for 1 year12.63-2.68-470%
Returns for 3 years14.16-16.04-88%
Returns for 5 years40.390.974,167%
Returns for 10 years61.843.331,855%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
REKR0.83N/A
-0.01%
Rekor Systems
CRBG29.99-0.44
-1.45%
Corebridge Financial
WHD61.48-1.46
-2.32%
Cactus
ABCL2.79-0.07
-2.45%
AbCellera Biologics
TRIB0.85-0.05
-5.67%
Trinity Biotech plc